S. Cantin

Design, synthesis, and biological evaluation of peptidomimetic inhibitors of factor XIa as novel anticoagulants.

R. Babine, S. Abdel-Meguid, M. Rynkiewicz, 2006, Journal of medicinal chemistry.

Discovery of CC-99677, a Selective Targeted Covalent MAPKAPK2 (MK2) Inhibitor for Autoimmune Disorders.

C. Chuaqui, T. Oravecz, J. McDonald, 2022, Translational research : the journal of laboratory and clinical medicine.

The Three-dimensional Structure of the ZAP-70 Kinase Domain in Complex with Staurosporine

Eugene C. Petrella, R. Babine, K. Seidl, 2004, Journal of Biological Chemistry.

Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in mice

Georg Rast, Bastian Hengerer, T. Strassmaier, 2018, PloS one.

Systemic nano-delivery of low-dose STING agonist targeted to CD103+ dendritic cells for cancer immunotherapy.

Deanna A. Mele, M. Amiji, S. Cantin, 2022, Journal of controlled release : official journal of the Controlled Release Society.

STAT3 Antisense Oligonucleotide Remodels the Suppressive Tumor Microenvironment to Enhance Immune Activation in Combination with Anti–PD-L1

Mingchao Xie, S. Barry, J. Barrett, 2020, Clinical Cancer Research.

SMaSh: A Streptavidin Mass Shift Assay for Rapidly Quantifying Target Occupancy by Irreversible Inhibitors.

L. Bateman, M. Labenski, Lixin Qiao, 2021, Biochemistry.

XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors as Evidenced by Preclinical Studies

Magali Pederzoli-Ribeil, C. U. Bialucha, Wilson Guzman, 2023, Molecular cancer therapeutics.